Company Filing History:
Years Active: 2011
Title: **John Roy Rohde: Innovator in Protein Engineering**
Introduction
John Roy Rohde is an accomplished inventor based in Paris, France, recognized for his innovative contributions to the field of protein engineering. With a focus on the manipulation of cellular processes, he holds a significant patent that showcases his expertise and vision in biotechnology.
Latest Patents
Rohde's notable patent is titled "Targeted ubiquitination of proteins and screening methods using a new class of ubiquitin ligase proteins." This invention introduces a novel class of E3 ubiquitin ligases derived from the IpaH superfamily. These proteins are essential for engineering products that can modulate the trafficking and destruction of target proteins within cells. Additionally, this patent opens pathways for identifying new antimicrobial molecules that specifically inhibit E3 ligases, presenting valuable opportunities in medical and research applications.
Career Highlights
Currently, John Roy Rohde is associated with Iti Scotland Limited, where he continues to explore innovative solutions in biotechnology. His work emphasizes the intricate manipulation of cellular pathways, aiming to improve therapeutic targets in various diseases. Rohde's patent reflects his commitment to advancing scientific understanding and practical applications in protein function and degradation.
Collaborations
Throughout his career, Rohde has collaborated with notable professionals such as Claude Rene Raoul Parsot and Philippe J Sansonetti. These partnerships illustrate the synergy between experts in the field and their collective efforts towards groundbreaking discoveries in biotechnology.
Conclusion
John Roy Rohde stands out as a key figure in the realm of protein engineering, with his patent significantly contributing to the understanding and manipulation of cellular mechanisms. His innovative work not only highlights his individual expertise but also emphasizes the collaborative spirit within the scientific community, aiming towards advancements in health and disease management.